看好AKK菌产业链投资机会

Investment Rating - The report maintains a "Buy" rating for H&H International Holdings and By-Health Co., Ltd. [8][10] Core Insights - The AKK probiotic market is expected to grow significantly, with the global market projected to reach approximately 2.35 billion RMB in 2024 and 4.46 billion RMB by 2031, reflecting a CAGR of 9.6% [3] - The Chinese probiotic market is anticipated to exceed 137.7 billion RMB by 2026, driven by a growth rate of 11-12% in recent years [2] - The AKK probiotic has shown promising effects in improving obesity, regulating blood sugar and lipids, and has potential anti-aging benefits [1][2] Summary by Sections Market Potential - The Chinese probiotic market is rapidly expanding, with significant growth in various application sectors, including food and beverages (67%), dietary supplements (19%), healthcare (6%), animal nutrition (5%), and personal care (3%) [2] - The demand for AKK probiotics is expected to accelerate due to its clear efficacy and technological advancements in industrial production [2][4] Technological Advancements - Recent breakthroughs in the cultivation of AKK probiotics have improved supply stability, allowing for industrial-scale production [3][4] - The approval of AKK as a new food ingredient in regions like the EU and Australia indicates its safety and potential for broader market acceptance [4] Investment Opportunities - The report highlights investment opportunities in the AKK probiotic supply chain, recommending companies like H&H International Holdings and By-Health Co., Ltd. for their proactive engagement in this emerging market [5][8] - H&H International Holdings is noted for its product reserves related to AKK, while By-Health is expanding its product range to meet diverse consumer needs [5][11]